Shares of Nemus Bioscience Inc (OTCMKTS:NMUS – Get Free Report) crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.78 and traded as low as $0.72. Nemus Bioscience shares last traded at $0.7701, with a volume of 168,687 shares changing hands.
Nemus Bioscience Trading Down 5.4%
The company has a market capitalization of $98.18 million, a price-to-earnings ratio of -8.15 and a beta of -0.04. The business’s fifty day moving average price is $0.78.
About Nemus Bioscience
Nemus Bioscience, Inc is an early‐stage biopharmaceutical company developing proprietary prodrug cannabinoid therapeutics for ophthalmic, dermatological and metabolic diseases. The company leverages synthetic derivatives of naturally occurring cannabinoids, designed to improve bioavailability, tissue targeting and therapeutic efficacy. Nemus operates under an OTCMKTS listing and is headquartered in Houston, Texas.
The company’s pipeline includes multiple preclinical candidates, with lead programs focusing on ophthalmic and dermatological indications.
Read More
- Five stocks we like better than Nemus Bioscience
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for Nemus Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nemus Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
